The Vancouver Sun reports in its Saturday edition QLT shareholders on Friday approved a special cash distribution of $200-million, which will see investors get $3.92 per share (all figures U.S.). A Canadian Press dispatch to The Sun says record date for the special distribution, first announced in April, is June 24. The Vancouver drug maker was once one of Canada's most commercially successful biotechnology companies based on the success of its Visudyne treatment for a common form of age-related blindness. However, the company has no come up with another big seller and shareholders have pushed QLT to downsize, resulting in a reduction of its work force by more than 80 per cent and the sale of Visudyne. QLT said its board had initially been authorized to return $100-million in capital, but that doubled with Friday's shareholder vote. Combined with a previous repurchase of QLT stock, the distribution will bring the total return of capital to $227-million over the past 12 months. QLT shares rose 10 cents Friday to close at $8.25 on the Toronto Stock Exchange.